Brian Powl
Corporate Officer/Principal bij KURA ONCOLOGY, INC.
Vermogen: 444 235 $ op 30-04-2024
Actieve functies van Brian Powl
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | 14-08-2023 | - |
Loopbaan van Brian Powl
Eerdere bekende functies van Brian Powl
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 30-06-2022 | - |
| MEI PHARMA, INC. | Verkoop & Marketing | 15-09-2020 | - |
Opleiding van Brian Powl
| University of California San Diego | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 3 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Brian Powl
- Ervaring